Complete Up To Date Information about Stenorol Type A Medicated Article.
NADA Number: 140-824 | |
| Proprietary Name |
Stenorol® Type A Medicated Article |
|---|---|
| Sponsor |
Huvepharma AD |
| Sponsor Address |
33 James Boucher Blvd. Sophia 1407, Bulgaria |
| Ingredients |
Halofuginone Hydrobromide |
| Species |
Turkey, growing |
| Routes of Administration |
Per Os |
| Dose Form |
Medicated feed |
| Drug Form |
Type A Medicated Article |
| Dispensing Status |
OTC |
| Withdrawal Time |
Growing Turkey: 7 days before slaughter. |
|
Dosage Amount, Indications & Limitations |
558.265 Halofuginone hydrobromide. Specifications: Type A medicated articles: 6 grams per kilogram (2.72 grams per pound) Conditions of use: Turkeys Amount: 1.36 to 2.72 grams per ton of feed. Indications: For the prevention of coccidiosis in growing turkeys caused by Eimeria adenoeides, E. meleagrimitis and E. gallopavonis. Limitations: Feed continuously as sole ration. Withdraw 7 days before slaughter. Do not feed to layers or water fowl. Avoid contact with skin, eyes, or clothing. Keep out of lakes, ponds, or streams. |
| Tolerances |
The marker residue selected to monitor for total residues of halofuginone hydrobromide in broilers and turkeys is parent halofuginone hydrobromide and the target tissue selected is liver. A tolerance is established in broilers of 0.16 part per million and in turkeys of 0.13 part per million for parent halofuginone hydrobromide in liver. These marker residue concentrations in liver correspond to total residue concentrations of 0.3 part per million in liver. |